BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 26043385)

  • 41. Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial.
    Jäger U; D'Sa S; Schörgenhofer C; Bartko J; Derhaschnig U; Sillaber C; Jilma-Stohlawetz P; Fillitz M; Schenk T; Patou G; Panicker S; Parry GC; Gilbert JC; Jilma B
    Blood; 2019 Feb; 133(9):893-901. PubMed ID: 30559259
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current Treatment Options in Cold Agglutinin Disease: B-Cell Directed or Complement Directed Therapy?
    Berentsen S; Tjønnfjord GE
    Transfus Med Rev; 2022 Oct; 36(4):181-187. PubMed ID: 36127205
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cold antibody autoimmune hemolytic anemias.
    Petz LD
    Blood Rev; 2008 Jan; 22(1):1-15. PubMed ID: 17904258
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A case of cold agglutinin syndrome associated with chronic lymphocytic leukaemia harbouring mutations in CARD11 and KMT2D.
    Fukatsu M; Hamazaki Y; Sato Y; Koyama D; Ikezoe T
    Int J Hematol; 2023 Oct; 118(4):472-476. PubMed ID: 37133636
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Warm autoimmune hemolytic anemia.
    Naik R
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):445-53. PubMed ID: 26043384
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia in Association with Antiphospholipid Syndrome.
    Gelman R; Kharouf F; Ishay Y; Gural A
    Acta Haematol; 2021; 144(6):693-697. PubMed ID: 34000726
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serologic diagnosis in the differentiation of autoimmune hemolytic anemias.
    Gologan R; Berceanu S
    Med Interne; 1979; 17(2):191-6. PubMed ID: 472642
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Updates on the Diagnosis and Management of Cold Autoimmune Hemolytic Anemia.
    Gertz MA
    Hematol Oncol Clin North Am; 2022 Apr; 36(2):341-352. PubMed ID: 35282954
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cold AIHA and the best treatment strategies.
    Despotovic JM; Kim TO
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):90-95. PubMed ID: 36485161
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel insights into the treatment of complement-mediated hemolytic anemias.
    Berentsen S; Hill A; Hill QA; Tvedt THA; Michel M
    Ther Adv Hematol; 2019; 10():2040620719873321. PubMed ID: 31523413
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cold agglutinin disease.
    Gertz MA
    Haematologica; 2006 Apr; 91(4):439-41. PubMed ID: 16585009
    [No Abstract]   [Full Text] [Related]  

  • 52. Three different pathways of IgM-antibody-dependent hemolysis are mainly regulated by complement.
    Bartolmäs T; Pruß A; Mayer B
    Front Immunol; 2023; 14():1114509. PubMed ID: 36817469
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The variability of hemolysis in the cold agglutinin syndrome.
    Rosse WF; Adams JP
    Blood; 1980 Sep; 56(3):409-16. PubMed ID: 7407408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket?
    Berentsen S; Fattizzo B; Barcellini W
    Front Immunol; 2023; 14():1180509. PubMed ID: 37168855
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complement-mediated hemolysis persists year round in patients with cold agglutinin disease.
    Röth A; Fryzek J; Jiang X; Reichert H; Patel P; Su J; Morales Arias J; Broome CM
    Transfusion; 2022 Jan; 62(1):51-59. PubMed ID: 34813663
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Autoimmune hemolytic anemia caused by anti-D antibody and a lymphoproliferative process in a patient with a kidney transplant immunosuppressed with cyclosporine].
    Oyonarte S; Cabello M; Clavero C; García Corzo G; Maldonado J
    Med Clin (Barc); 1988 Apr; 90(13):545-7. PubMed ID: 2839744
    [No Abstract]   [Full Text] [Related]  

  • 57. TNT003, an inhibitor of the serine protease C1s, prevents complement activation induced by cold agglutinins.
    Shi J; Rose EL; Singh A; Hussain S; Stagliano NE; Parry GC; Panicker S
    Blood; 2014 Jun; 123(26):4015-22. PubMed ID: 24695853
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Successful Management of Refractory Autoimmune Hemolytic Anemia with Cold Agglutinin Disease with Splenectomy: A Case Report with Review of Literature.
    Okamoto S; Urade T; Yakushijin K; Kido M; Kuramitsu K; Komatsu S; Gon H; Yamashita H; Shirakawa S; Tsugawa D; Terai S; Yanagimoto H; Toyama H; Fukumoto T
    Kobe J Med Sci; 2023 Jan; 68(1):E30-E34. PubMed ID: 36647084
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Chronic cold agglutinin disease].
    Berentsen S
    Tidsskr Nor Laegeforen; 1995 Feb; 115(4):473-5. PubMed ID: 7871504
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cold agglutinin anti-I antibodies in two patients with COVID-19.
    Imoto H; Yoshioka S; Nakagawa D; Hasegawa K; Kuroda H; Hasuike T; Doi A; Kusumoto T; Ishikawa T
    J Clin Lab Anal; 2022 Sep; 36(9):e24629. PubMed ID: 35917437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.